Profile Information

Professional (Medical) Affiliation
Medical Research, Pharma, Academia

Peter Hofland

Peter Hofland, PhD's Friends

  • jane Walton
  • Kashif
  • Dr.Amin Delawalla
  • Kyu Lim
  • Frank
  • Danielle Friedman
  • Borsani Luisa
  • Dr mir khan
  • Sarah Krug
  • Randy Burton
  • Gideon van der Watt
  • Folkert Tempelman
  • Peter Janssen
  • Camille DeSantis
  • Eiji Sasahara, Ph.D., MBA 笹原英司

Peter Hofland, PhD's Videos

  • Add Videos
  • View All

Gifts Received


Peter Hofland, PhD has not received any gifts yet

Give a Gift


Peter Hofland, PhD's Page

Comment Wall (2 comments)

You need to be a member of Onco'Zine to add comments!

Join Onco'Zine

At 12:04pm on January 28, 2013, Ryan Harris said…

This is a new way to network.

At 5:04pm on March 21, 2011, OncologyTube said…

Hi Peter -


Are you going to be at ASCO this year? I would love to meet you and perhaps talk more about some business ideas.


Allen Wilbanks


Peter Hofland, PhD's Photos

  • Add Photos
  • View All

Peter Hofland, PhD's Discussions

Bioethicist Says Lying to Patients is Not Huge Ethical Failure

Started Feb 14, 2012 0 Replies

Published today Online at Medscape Internal Medicine, Art Caplan PhD, a Bioethicist at the University of Pennsylvania, Department of Medical Ethics and Health Policy, commented on the question…Continue

Tags: Failure, Ethical, Patients, Lying, Bioethicist

Peter Hofland, PhD's Blog

Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking - 50 Years After First Surgeon General Report

Posted on January 10, 2014 at 2:30pm 0 Comments

Each year, more than 440,000 Americans die from smoking. Eight million Americans live with at least one serious chronic disease from smoking. The cost to U.S economy is $193 billion a year, with nearly $96 billion in direct medical costs and an additional $97 billion in lost productivity. But change is looming on the horizon.[1]

January 2014 marks the 50th anniversary of the first Surgeon General's report on Smoking and Health. On January 11, 1964,  Luther L. Terry,…


Phase III PANCRIT-1 Study Starts Accrual of Patients with Metastatic Pancreatic Cancer

Posted on January 9, 2014 at 8:30pm 0 Comments

The PANcreatic Cancer RadioImmunotherapy Trial-1 (PANCRIT-1) starts its patient accrual phase. This trial is a double-blind, randomized study and will enroll approximately 440 patients with metastatic pancreatic cancer. A majority of patients will be recruited at clinical trial sites across the United States, with additional sites in Canada, Europe and Israel participating. Eligible patients will be randomized 2 to 1 to the treatment arm of 3 doses of 90Y-clivatuzumab tetraxetan (…


U.S. FDA Approves Combination of Trametinib and Dabrafenib for Unresectable or Metastatic Melanoma

Posted on January 9, 2014 at 5:30pm 0 Comments

The U.S. Food and Drug Administration (U.S.FDA) has approved trametinib (Mekinist®; Glaxosmithkline/GSK) for use in combination with dabrafenib (Tafinlar®;Glaxosmithkline/GSK) for the treatment of patients with unresectable melanoma or metastatic melanoma with BRAF V600E or V600K mutations. These mutations must be detected by an FDA-approved companion…


Molecular Protein Targeting Therapies may Offer the Best Treatment for Certain Lung Cancer

Posted on January 7, 2014 at 4:00pm 0 Comments

Researchers at the University of Cincinnati (UC) Cancer Institute have found that using therapies specifically targeting the molecular profile of non-small-cell lung cancer (NSCLC) with the mutated cancer-causing protein KRas is the most effective treatment strategy for patients with that condition.

These findings are presented via poster at the American Association for Cancer Research (AACR)–International Association for the…


New Approach of Piggy-backing Proteins may help Wipe Out Metastasizing Cancer

Posted on January 6, 2014 at 4:00pm 0 Comments

In many types of cancer cells from the primary tumor can intravasate into the bloodstream as circulating tumor cells or CTCs. These CTCs can then interact with the receptor-bearing endothelial cell wall. The process is similar to leukocyte extravasation - the flow of blood or lymph-fluid into surrounding tissue during inflammation.

Now for the first time biomedical engineers at Cornell University inIthaca in New York, NY have discovered a new way to destroy these…


Researchers Prevent Brain Cancer Recurrence by Attacking Tumors at the Source

Posted on January 6, 2014 at 3:00pm 0 Comments

Targeting cancer stem cells (CSCs) - cells from which malignant brain tumors are believed to originate and regenerate- with immunotherapy may be an effective means to prevent recurrences in glioblastoma multiforme (GBM). Researchers at the Cedars-Sinai Maxine Dunitz Neurosurgical Institute and Department of…


The War on Cancer: From Promises Made by President Nixon Until Now

Posted on November 4, 2013 at 10:00pm 0 Comments

Finding a cure for cancer - the second-leading cause of death in the United States - was what the American people really wanted in 1970. In response, President Nixon, in the January 1971 State of the Union address said: "I will also ask for an appropriation of an extra $100 million to launch an intensive campaign to find a cure for cancer, and I will ask later for whatever additional funds can effectively be used. The time…


Researchers Increase Survival in Mice with Glioblastoma by Silencing a Troublesome Oncogene

Posted on October 30, 2013 at 10:30pm 0 Comments

Glioblastoma multiform or  GBM, the brain cancer that killed Senator Edward M. Kennedy of Massachusetts and kills approximately 13,000 Americans a year, is aggressive and incurable. Now a team of researchers at Northwestern University (Evanston, Illinois) is the team first to demonstrate delivery of a drug that turns off a critical gene in this complex cancer, increasing survival rates significantly in…


No Increased Mortality Risks for Early-stage Breast Cancer Patients Receiving XRT

Posted on September 24, 2013 at 8:30am 0 Comments

According to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting, being held in Atlanta,September 22-25, 2013, early-stage breast cancer patients who receive external beam therapy or XRT are not at higher risk for serious long-term side effects in the chest area, including increase in deaths from cardiac disease and secondary malignancies.

Various studies have shown that…


Sulfasalazine Fails to Reduce Diarrhea in Patients Receiving Radiation Therapy

Posted on September 24, 2013 at 6:00am 0 Comments

Results of a study presented today at the American Society of Radiation Oncology's (ASTRO's) 55th Annual Meeting held in Atlanta, September 22-25, 2013 shows that Sulfasalazine (Azulfidine®, Pfizer), a drug commonly prescribed to reduce diarrhea in patients with rectal bleeding and abdominal pain in patients with ulcerative colitis, a condition in which the bowel is inflamed, does not reduce diarrhea in patients receiving radiation therapy for cancers in the pelvic area.[1] The study…



Surgeon General’s Report on Smoking & Health—50th Anniversary: 1964-2014

Onco'Zine is present here

© 2014   Created by Peter Hofland, PhD.

Badges  |  Report an Issue  |  Terms of Service

Find us on Google+